Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Postoperative Nausea and Vomiting (PONV) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Postoperative Nausea and Vomiting (PONV) market.
Major Players in the Postoperative Nausea and Vomiting (PONV) market are:
F. Hoffmann-La Roche
Ani Pharmaceuticals
Merck
Helsinn Holding
Acacia Pharma
Eisai
Sanofi
GlaxoSmithKline
Novartis
Camurus
On the basis of types, the Postoperative Nausea and Vomiting (PONV) market is primarily split into:
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
On the basis of applications, the market covers:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Postoperative Nausea and Vomiting (PONV) Market Overview
- 1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV) Market
- 1.2 Postoperative Nausea and Vomiting (PONV) Market Segment by Type
- 1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Postoperative Nausea and Vomiting (PONV) Market Segment by Application
- 1.3.1 Postoperative Nausea and Vomiting (PONV) Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Postoperative Nausea and Vomiting (PONV) Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Postoperative Nausea and Vomiting (PONV) (2017-2029)
- 1.5.1 Global Postoperative Nausea and Vomiting (PONV) Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Postoperative Nausea and Vomiting (PONV) Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Postoperative Nausea and Vomiting (PONV) Industry
- 1.7 Impact of Carbon Neutrality on the Postoperative Nausea and Vomiting (PONV) Industry
- 2 Postoperative Nausea and Vomiting (PONV) Market Upstream and Downstream Analysis
- 2.1 Postoperative Nausea and Vomiting (PONV) Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Postoperative Nausea and Vomiting (PONV) Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 F. Hoffmann-La Roche
- 3.1.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Ani Pharmaceuticals
- 3.2.1 Ani Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Merck
- 3.3.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Helsinn Holding
- 3.4.1 Helsinn Holding Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Acacia Pharma
- 3.5.1 Acacia Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Eisai
- 3.6.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Sanofi
- 3.7.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 GlaxoSmithKline
- 3.8.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Novartis
- 3.9.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Camurus
- 3.10.1 Camurus Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Postoperative Nausea and Vomiting (PONV) Market Performance (2017-2022)
- 3.10.4 Business Overview
- 4 Global Postoperative Nausea and Vomiting (PONV) Market Landscape by Player
- 4.1 Global Postoperative Nausea and Vomiting (PONV) Sales and Share by Player (2017-2022)
- 4.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Player (2017-2022)
- 4.3 Global Postoperative Nausea and Vomiting (PONV) Average Price by Player (2017-2022)
- 4.4 Global Postoperative Nausea and Vomiting (PONV) Gross Margin by Player (2017-2022)
- 4.5 Postoperative Nausea and Vomiting (PONV) Market Competitive Situation and Trends
- 4.5.1 Postoperative Nausea and Vomiting (PONV) Market Concentration Rate
- 4.5.2 Postoperative Nausea and Vomiting (PONV) Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price Trend by Type
- 5.1 Global Postoperative Nausea and Vomiting (PONV) Sales and Market Share by Type (2017-2022)
- 5.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2017-2022)
- 5.3 Global Postoperative Nausea and Vomiting (PONV) Price by Type (2017-2022)
- 5.4 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of Serotonin Antagonists (2017-2022)
- 5.4.2 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of Steroids (2017-2022)
- 5.4.3 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of Dopamine Antagonists (2017-2022)
- 5.4.4 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of NK-1 Receptor Antagonists (2017-2022)
- 5.4.5 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of Non-pharmacologic Treatment (2017-2022)
- 5.4.6 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Growth Rate of Others (2017-2022)
- 6 Global Postoperative Nausea and Vomiting (PONV) Market Analysis by Application
- 6.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Market Share by Application (2017-2022)
- 6.2 Global Postoperative Nausea and Vomiting (PONV) Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
- 6.3.2 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate of Online Pharmacies (2017-2022)
- 6.3.3 Global Postoperative Nausea and Vomiting (PONV) Consumption and Growth Rate of Retail Pharmacies (2017-2022)
- 7 Global Postoperative Nausea and Vomiting (PONV) Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Postoperative Nausea and Vomiting (PONV) Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Postoperative Nausea and Vomiting (PONV) Market Forecast (2022-2029)
- 8.1 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Postoperative Nausea and Vomiting (PONV) Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Postoperative Nausea and Vomiting (PONV) Price and Trend Forecast (2022-2029)
- 8.2 Global Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Sales and Revenue Forecast (2022-2029)
- 8.3 Global Postoperative Nausea and Vomiting (PONV) Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of Serotonin Antagonists (2022-2029)
- 8.3.2 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of Steroids (2022-2029)
- 8.3.3 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of Dopamine Antagonists (2022-2029)
- 8.3.4 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of NK-1 Receptor Antagonists (2022-2029)
- 8.3.5 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of Non-pharmacologic Treatment (2022-2029)
- 8.3.6 Global Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate of Others (2022-2029)
- 8.4 Global Postoperative Nausea and Vomiting (PONV) Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Postoperative Nausea and Vomiting (PONV) Consumption Value and Growth Rate of Hospital Pharmacies (2022-2029)
- 8.4.2 Global Postoperative Nausea and Vomiting (PONV) Consumption Value and Growth Rate of Online Pharmacies (2022-2029)
- 8.4.3 Global Postoperative Nausea and Vomiting (PONV) Consumption Value and Growth Rate of Retail Pharmacies (2022-2029)
- 8.5 Postoperative Nausea and Vomiting (PONV) Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Postoperative Nausea and Vomiting (PONV) Market Drivers Analysis
- 9.2 Postoperative Nausea and Vomiting (PONV) Market Restraints and Challenges
- 9.3 Postoperative Nausea and Vomiting (PONV) Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Postoperative Nausea and Vomiting (PONV) Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Postoperative Nausea and Vomiting (PONV) Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Postoperative Nausea and Vomiting (PONV) Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook